2-[(2-fluorophenyl)methoxy]-5-(4-methylphenyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;2-[(4-fluorophenyl)methoxy]-5-(4-methylphenyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2-fluorophenyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylphenyl)-2-[(3-methylphenyl)methoxy]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(3-methylphenyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylphenyl)-2-(pyridin-2-ylmethoxy)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one
C119H110F3N19O12 — CID 158618121
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[(2-fluorophenyl)methoxy]-5-(4-methylphenyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;2-[(4-fluorophenyl)methoxy]-5-(4-methylphenyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2-fluorophenyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylphenyl)-2-[(3-methylphenyl)methoxy]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(3-methylphenyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylphenyl)-2-(pyridin-2-ylmethoxy)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one
2-[(2-fluorophenyl)methoxy]-5-(4-methylphenyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;2-[(4-fluorophenyl)methoxy]-5-(4-methylphenyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2-fluorophenyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylphenyl)-2-[(3-methylphenyl)methoxy]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(3-methylphenyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylphenyl)-2-(pyridin-2-ylmethoxy)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one (PubChem CID 158618121) has the molecular formula C119H110F3N19O12 and a molecular weight of 2055.30 g/mol. Its IUPAC name is 2-[(2-fluorophenyl)methoxy]-5-(4-methylphenyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;2-[(4-fluorophenyl)methoxy]-5-(4-methylphenyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2-fluorophenyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylphenyl)-2-[(3-methylphenyl)methoxy]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(3-methylphenyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylphenyl)-2-(pyridin-2-ylmethoxy)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one.
Molecular Properties
| Compound Name | 2-[(2-fluorophenyl)methoxy]-5-(4-methylphenyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;2-[(4-fluorophenyl)methoxy]-5-(4-methylphenyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2-fluorophenyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylphenyl)-2-[(3-methylphenyl)methoxy]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(3-methylphenyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylphenyl)-2-(pyridin-2-ylmethoxy)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one |
|---|---|
| PubChem CID | 158618121 |
| Molecular Formula | C119H110F3N19O12 |
| Molecular Weight | 2055.30 g/mol |
| Exact Mass | 2053.85 |
| IUPAC Name | 2-[(2-fluorophenyl)methoxy]-5-(4-methylphenyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;2-[(4-fluorophenyl)methoxy]-5-(4-methylphenyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2-fluorophenyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylphenyl)-2-[(3-methylphenyl)methoxy]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(3-methylphenyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(4-methylphenyl)-2-(pyridin-2-ylmethoxy)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one |
| SMILES | Cc1ccc(N2CCn3nc(OCc4ccc(F)cc4)cc3C2=O)cc1.Cc1ccc(N2CCn3nc(OCc4cccc(C)c4)cc3C2=O)cc1.Cc1ccc(N2CCn3nc(OCc4ccccc4F)cc3C2=O)cc1.Cc1ccc(N2CCn3nc(OCc4ccccn4)cc3C2=O)cc1.Cc1cccc(N2CCn3nc(OCc4ccccc4)cc3C2=O)c1.O=C1c2cc(OCc3ccccc3)nn2CCN1c1ccccc1F |
| InChI | InChI=1S/C21H21N3O2.2C20H18FN3O2.C20H19N3O2.C19H16FN3O2.C19H18N4O2/c1-15-6-8-18(9-7-15)23-10-11-24-19(21(23)25)13-20(22-24)26-14-17-5-3-4-16(2)12-17;1-14-2-8-17(9-3-14)23-10-11-24-18(20(23)25)12-19(22-24)26-13-15-4-6-16(21)7-5-15;1-14-6-8-16(9-7-14)23-10-11-24-18(20(23)25)12-19(22-24)26-13-15-4-2-3-5-17(15)21;1-15-6-5-9-17(12-15)22-10-11-23-18(20(22)24)13-19(21-23)25-14-16-7-3-2-4-8-16;20-15-8-4-5-9-16(15)22-10-11-23-17(19(22)24)12-18(21-23)25-13-14-6-2-1-3-7-14;1-14-5-7-16(8-6-14)22-10-11-23-17(19(22)24)12-18(21-23)25-13-15-4-2-3-9-20-15/h3-9,12-13H,10-11,14H2,1-2H3;2*2-9,12H,10-11,13H2,1H3;2-9,12-13H,10-11,14H2,1H3;1-9,12H,10-11,13H2;2-9,12H,10-11,13H2,1H3 |
| InChIKey | HXQLZSUTHNSHOX-UHFFFAOYSA-N |
| XLogP | 20.40 |
| TPSA | 297.05 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 25 |
| Rotatable Bonds | 24 |
| Heavy Atoms | 153 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2055.30 |
| LogP ≤ 5 | 20.40 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 25 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158618121 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.